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from 41 to 78 years (mean 59.7+4.3). Mean number of shunts per patient was 2,5. All
2707 shunts were distributed as follows: 977 (36%) autoarterial shunts using internal
mammary artery to the system of the left coronary artery (LAD and DB); 998 (37%)
autovenous shunts to the system of the left coronary artery (CxB, OMB, Intermedia,
DB, LAD); 732 (27%) autovenous shunts to the system of the right coronary artery.
Thus, autoarterial shunts were used in 36% and autovenous shunts – in 64% of cases.
In 672 (62%) cases the operations were performed under extracorporeal circulation,
and in 412 (38%) cases – on the beating heart.
Results: The problems in shunts or in shunted arteries were revealed in 289 (26,6%)
patients, hence, the rate of complications as calculated for the totality of shunts is
10,7%. In 153 (53%) cases the stenoses were revealed in the site of distal anastomosis
or the native artery beyond it the degree of stenosis varied from 50 to 90%. In 56 (19%)
cases the stenoses of mammaro-coronary shunt were revealed, in 40 (14%) – venous
shunt occlusions, in 24 (8%) – native artery occlusions and in 16 (6%) – mammaro-
coronary shunt occlusions. In 100 (34,6%) repeated interventions with subsequent
control shuntography were performed: in 9 (9%) the revealed lesion was corrected by
stenting, in 91 (91%) cases surgery was applied.
Conclusion: Intraoperative shuntography can reveal certain technical problems related
to immediate shunts performance, which can lead to early angina recurrence and shunts
occlusion in early postoperative period. Intraoperative solution of these problems
contributes to the improvement of immediate as well as of long-term results of
aortocoronary bypass surgery.
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Background: The MiStent consists of a cobalt chromium stent with a PLGA
bioabsorbable polymer and sirolimus, enabling complete drug elution and polymer
absorption within 90 days. DESSOLVE-I is a single-arm, multicenter, first-in-man
trial, enrolling 30 patients with follow-up at 4, 6, or 8 months (10 patients each) and
18 months (all). This study aimed to evaluate initial arterial response to MiStent in de
novo human coronary lesions.
Methods: In the 4-month cohort, volume index (VI: volume/length) was serially
obtained in 10 patients. Neointimal obstruction was calculated as neointima/stent
volume. Cross-sectional narrowing (CSN) was defined as neointima/stent area. Gross
coverage of struts was assessed as neointima-free frame ratio (number of frames
without neointima/total frame number).
Results: No significant changes were observed in vessel, plaque, or lumen VI during
follow-up. Neointima at 4 months was minimum, and no case showed significant
lumen encroachment. Neointima-free frame ratio was 20.2±16.6% (Cypher: 64±26%
and Xience: 39±27% at 8-9 months in historical database), indicating the large part of
the MiStent covered by neointima at 4 months. One case had late-acquired incomplete
stent apposition. There was no target lesion revascularization, cardiac death or stent
thrombosis.
Conclusion: Preliminary IVUS results from the first-in-man trial showed that the
MiStent with sirolimus and bioabsorbable polymer had rapid and uniform neointimal
coverage with no adverse vessel reaction. Follow-up of 6 and 8-month cohorts are
ongoing.
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Background: Device closure of Ostium Secundum Atrial Septal Defect (OSASD) is
done in patients with Pulmonary artery systolic pressure(PASP) less than 2/3rd of
systemic arterial systolic pressure(SASP).Little is known about device closure in
patients with OSASD who have PASP>2/3rd of SASP.
Methods: During August 2007 and December 2010, we attempted device closure of
94 patients,between age group 4years to 60 years.Out of 94, 9 patients had PASP >2/3
rd of SASP.We used our own clinical scoring system to identify patients for device
closure.All patients were pretreated with oral sildenafil for 3 weeks prior to planned
catheterization and device closure.
Results: All patients were females.the mean age was 42.5+/-11.5 years( Range 22-57
years).The mean PASP was 93.67 +/- 19.97 mmHg( range 72-140 mm Hg) and mean
SASP was 120.11 +/-13.20 mmHg(range106-160 mm Hg) .All patients had Qp:Qs >
1.5:1 and Rp/Rs <0.5. The mean follow -up PASP was 44.0+/-17.23 mmHg(range 30-
78 mmHg).More than 50% drop in PASP from baseline was noted in 7 out of 9 patients,
with PASP <45 mm Hg in 6 patients and 58 mmHg in 1 patient. Two patients had
significant fall in PASP though it remained 65 mm Hg in one patient and 78 mm Hg
in another patient.All patients improved from NYHA Class III to Asymptomatic or
functional class I.Three patients were noted to have additional respiratory component
contributing to the clinical picture.These patients showed dramatic improvement after
device closure. The patients received Sidenafil for 6 months or upto normalisation of
PASP. Sildenafil was not associated with improvement in clinical outcome.
Conclusion: Device closure in selected patients with OSASD and severe PAH is safe
and improves PASP,functional class and quality of life.
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Background: R to L shunting, usually caused by a patent foramen ovale (PFO), is
associated with migraine headache (MH) with aura. There are patients who present
with visual aura but deny headaches. It is unclear whether visual aura without headache
is a form of migraine (“visual migraine”) or is due to some other transient neurologic
dysfunction. This study assesses the prevalence of right to left (R to L) shunt in patients
presenting with visual aura and evaluates if aura resolves following closure of PFO.
Methods: Of 590 patients referred to UCLA for potential PFO related conditions, 225
patients had visual aura with or without MH. Patients were assessed for a R to L shunt
with Transcranial Doppler. They were evaluated for the presence of MH and/or visual
aura and then divided into three groups: 1) Group A (Aura + MH)- Aura during MH or
within 60 minutes of MH; 2) Group B (Aura unrelated to MH)- Aura not during MH
or within 60 minutes of MH; 3) Group C (Aura only)- visual aura without MH. The
frequency of R to L shunt was compared to a control group of 200 unselected patients
referred for diagnostic catheterization. 80 patients (approx. 1/3 per group) underwent
PFO closure. Residual MH and visual aura were assessed 12 months after the
procedure.
Results: The prevalence of R to L shunt in groups A, B, C and the control group were
96%, 72%, 67% and 18% respectively. The prevalence was similar in groups B vs. C
(p=0.66), but higher in group A due to selection bias. When compared to the control
group, the frequency of R to L shunt in all three groups was much higher (p<0.0001).
12 months after PFO closure, symptoms of visual aura were completely resolved in
52%, 75% and 80% of patients in groups A, B and C respectively (p=ns).
Conclusion: There is a strong correlation between PFO closure and improvement of
aura (with and without MH) suggesting a causative association between the presence
of PFO and the aura phenomenon. Since isolated visual aura has a similar prevalence
of R to L shunt and responds the same to PFO closure, it is likely similar in
pathophysiology to MH with aura.
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